Cargando…

A Novel Network Pharmacology Strategy to Decode Metabolic Biomarkers and Targets Interactions for Depression

Depression is one of the most prevalent and serious mental disorders with a worldwide significant health burden. Metabolic abnormalities and disorders in patients with depression have attracted great research attention. Thirty-six metabolic biomarkers of clinical plasma metabolomics were detected by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yao, Xu, Teng, Zhao, Ying-Xia, Ling-Hu, Ting, Liu, Shao-Bo, Tian, Jun-Sheng, Qin, Xue-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373779/ https://www.ncbi.nlm.nih.gov/pubmed/32760300 http://dx.doi.org/10.3389/fpsyt.2020.00667

Ejemplares similares

A Novel Network Pharmacology Strategy to Decode Mechanism of Lang Chuang Wan in Treating Systemic Lupus Erythematosus
por: Gao, Yao, et al.
Publicado: (2020)

Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder
por: Horne, Rachael, et al.
Publicado: (2018)

Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents
por: Jiang, Yuanliang, et al.
Publicado: (2022)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

Decoding Human Personality Through Dermatoglyphics
por: Venurkar, Shreya, et al.
Publicado: (2022)

Connectome-Based Biomarkers Predict Subclinical Depression and Identify Abnormal Brain Connections With the Lateral Habenula and Thalamus
por: Zhu, Yunkai, et al.
Publicado: (2019)

Mapping the structure of depression biomarker research: A bibliometric analysis
por: Guo, Xiang-jie, et al.
Publicado: (2022)

Cognitive Reserve Moderates Effects of White Matter Hyperintensity on Depressive Symptoms and Cognitive Function in Late-Life Depression
por: Lin, Chemin, et al.
Publicado: (2020)

Metabolic Profiling in Bipolar Disorder Patients During Depressive Episodes
por: Ren, Yan, et al.
Publicado: (2020)

Potential mechanisms underlying the therapeutic roles of sinisan formula in depression: Based on network pharmacology and molecular docking study
por: Wang, Hui, et al.
Publicado: (2022)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Serum Metabolic Profiling of Late-Pregnant Women With Antenatal Depressive Symptoms
por: Mao, Qiang, et al.
Publicado: (2021)

Vocal Acoustic Features as Potential Biomarkers for Identifying/Diagnosing Depression: A Cross-Sectional Study
por: Zhao, Qing, et al.
Publicado: (2022)

Neural Decoding of Multi-Modal Imagery Behavior Focusing on Temporal Complexity
por: Furutani, Naoki, et al.
Publicado: (2020)

Does urinary metabolite signature act as a biomarker of post-stroke depression?
por: Cai, Wa, et al.
Publicado: (2022)

Potential Biomarkers for Predicting Depression in Diabetes Mellitus
por: Song, Xiuli, et al.
Publicado: (2021)

Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis
por: Schiavone, Stefania, et al.
Publicado: (2017)

Aberrant degree centrality of functional brain networks in subclinical depression and major depressive disorder
por: Yang, Lei, et al.
Publicado: (2023)

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
por: Wang, Xue-Qin, et al.
Publicado: (2021)

L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder
por: Nie, Li-Juan, et al.
Publicado: (2021)

Editorial: Cognitive-related and connectome-based biomarkers for depression: the application of state-of-the-art techniques and models to uncover
por: Chen, Zhiyi, et al.
Publicado: (2023)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Hjorth, Stephan
Publicado: (2021)

Childhood Abuse, Social Support, and Long-Term Pharmacological Treatment Outcomes in Patients With Depressive Disorders
por: Lee, Ju-Yeon, et al.
Publicado: (2022)

Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
por: Qiu, Yuying, et al.
Publicado: (2023)

Body dysmorphic disorder and depression among male undergraduate students in a Malaysian University
por: Kang, Waye Hann, et al.
Publicado: (2022)

Efficacy of the Whole-Body Cryotherapy as Add-on Therapy to Pharmacological Treatment of Depression—A Randomized Controlled Trial
por: Rymaszewska, Joanna, et al.
Publicado: (2020)

Antidepressant effect r TMS during pregnancy in a case of Major Depression Resistant to Pharmacological Treatment
por: Isabel, Martínez-Gras, et al.
Publicado: (2021)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

Distributional Transformation Improves Decoding Accuracy When Predicting Chronological Age From Structural MRI
por: Soch, Joram
Publicado: (2020)

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
por: Young, Juan Joseph, et al.
Publicado: (2016)

D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
por: MacKay, Mary-Anne B., et al.
Publicado: (2019)

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
por: Tang, Yiguo, et al.
Publicado: (2021)

Postpartum Depression: Current Status and Possible Identification Using Biomarkers
por: Yu, Yi, et al.
Publicado: (2021)

Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?
por: Peräkylä, Jari, et al.
Publicado: (2021)

Research on the Development of Theme Trends and Changes of Knowledge Structures of Drug Therapy Studies on Major Depressive Disorder Since the 21(st) Century: A Bibliometric Analysis
por: Duan, Li, et al.
Publicado: (2020)

Plasma microRNA Array Analysis Identifies Overexpressed miR-19b-3p as a Biomarker of Bipolar Depression Distinguishing From Unipolar Depression
por: Chen, Yu, et al.
Publicado: (2020)

Characteristics of psychological time in patients with depression and potential intervention strategies
por: Ren, Hanlin, et al.
Publicado: (2023)

System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of Zhi-zhu Wan for Functional Dyspepsia
por: Wang, Chun, et al.
Publicado: (2018)

Association Between Antidepressant Efficacy and Interactions of Three Core Depression-Related Brain Networks in Major Depressive Disorder
por: Wang, Qiang, et al.
Publicado: (2022)

Decreased Plasma Hydrogen Sulfide Level Is Associated With the Severity of Depression in Patients With Depressive Disorder
por: Yang, Yuan-Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_smk7dgglhmpn1n665jualee0r3